Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Integrated BioPharma (INBP)
:INBP
INBP Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.16 - $0.42
Previous CloseN/A
Volume200.00
Average Volume (3M)17.77K
Market Cap
$9.86M
Enterprise Value$6.47M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)10.1
Beta0.29
Next Earnings
May 08, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding30,300,720
10 Day Avg. Volume37,843
30 Day Avg. Volume17,770
Standard Deviation0.16
R-Squared0.04
Alpha0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.19
Price to Cash Flow (P/CF)12.30
P/FCF Ratio12.30
Enterprise Value/Market Cap0.66
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.67
Enterprise Value/Ebitda3.66
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Ownership Overview
9.54% Insiders
―
Mutual Funds
― Other Institutional Investors
90.46% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
INBP FAQ
What was Integrated BioPharma ’s price range in the past 12 months?
Integrated BioPharma lowest stock price was $0.16 and its highest was $0.42 in the past 12 months.
What is Integrated BioPharma ’s market cap?
Integrated BioPharma ’s market cap is $9.86M.
When is Integrated BioPharma ’s upcoming earnings report date?
Integrated BioPharma ’s upcoming earnings report date is May 08, 2025 which is in 75 days.
How were Integrated BioPharma ’s earnings last quarter?
Integrated BioPharma released its earnings results on Feb 13, 2025. The company reported $0.004 earnings per share for the quarter, beating the consensus estimate of N/A by $0.004.
Is Integrated BioPharma overvalued?
According to Wall Street analysts Integrated BioPharma ’s price is currently Overvalued.
Does Integrated BioPharma pay dividends?
Integrated BioPharma does not currently pay dividends.
What is Integrated BioPharma ’s EPS estimate?
Integrated BioPharma ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Integrated BioPharma have?
Integrated BioPharma has 30,300,720 shares outstanding.
What happened to Integrated BioPharma ’s price movement after its last earnings report?
Integrated BioPharma reported an EPS of $0.004 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 15.385%.
Which hedge fund is a major shareholder of Integrated BioPharma ?
Currently, no hedge funds are holding shares in INBP
---
Company Description
Integrated BioPharma
Integrated BioPharma, Inc. engages in the manufacture, distribution, marketing, and sale of vitamins, nutritional supplements and herbal products. It operates through the following segments: Contract Manufacturing, Branded Proprietary Products, and Other Nutraceutical Businesses. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers and specialized health-care providers. The Branded Proprietary Products segment distributes nutritional products through mass market, grocery, drug and vitamin retailers. The Other Nutraceutical Businesses segment sells private label MDC products, as well as AgroLabs products. The company was founded by E. Gerald Kay in March 1980 and is headquartered in Hillside, NJ.
---
Technical Analysis
---